PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Neuropharmacology Laboratory, Drug Research and Development Center, Department of Physiology and Pharmacology, Faculty of Medicine, Universidade Federal Do Ceará, Fortaleza, CE, Brazil. adrianoafilho@hotmail.com.\', \'Laboratory for Molecular Modeling and Drug Design, LabMol, Faculty of Pharmacy, Universidade Federal de Goiás, Goiânia, GO, Brazil. adrianoafilho@hotmail.com.\', \'Critical Care Unit, Antônio Prudente Hospital- HAPFOR, Fortaleza, CE, Brazil. adrianoafilho@hotmail.com.\', \'Critical Care Unit, Antônio Prudente Hospital- HAPFOR, Fortaleza, CE, Brazil.\', \'Laboratory for Molecular Modeling and Drug Design, LabMol, Faculty of Pharmacy, Universidade Federal de Goiás, Goiânia, GO, Brazil.\', \'São Francisco Hospital, Ribeirão Preto, SP, Brazil.\', \'Neuropharmacology Laboratory, Drug Research and Development Center, Department of Physiology and Pharmacology, Faculty of Medicine, Universidade Federal Do Ceará, Fortaleza, CE, Brazil. danielle.macedo@ufc.br.\', \'National Institute for Translational Medicine (INCT-TM, CNPq), Ribeirão Preto, SP, Brazil. danielle.macedo@ufc.br.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s11481-021-09986-3
?:doi
?:hasPublicationType
?:journal
  • Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33534108
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all